Table 2.
An analysis of the MNPs for their use in stem cell tracking using MRI
Year | Type of MNP | How stem cells attached to SPIONs | Method of production of label | Clinical application | In vivo/in vitro | % of stem cells labeled | Effect on stem cells | How long the label remained detectable | Other |
---|---|---|---|---|---|---|---|---|---|
201148 | Gold nanoparticle coated with PLL or citrate solution | Passive uptake of the nanoparticles by the cells | Gold nanoparticles coated with PLL added to cell culture and incubated for 24 hours | MSC labeling, imaging, and tracking | In vitro (LIVE/DEAD stain) | NR | Not cytotoxic to the cells and did not substantially affect viability | NR | Cell uptake of the nanoparticle decreased |
201132 | USPIO-PS | Passive uptake of the nanoparticles by the cells | USPIOs are composed of maghemite cores modified on their surface by amino silane coupling agents | Labeling of hADSCs to assess their fate in vivo on a three-dimensional, porous scaffold | Mouse | 91% | Not toxic for the cells apart from a slight loss of metabolic activity at days 11 and 14 compared to the unlabelled cells | 28 days after implantation | USPIO allowed the visualization of 5 × 104 labeled hADSCs by MRI |
201165 | FE-Pro | Passive uptake of the nanoparticles by the cells | Ferumoxide–protamine sulfate complex was made with ferumoxides mixed with protamine sulfate solution | Labeling hB MSCs with FE-Pro to be tracked by MRI | Ex vivo | 95% | Did not harm cells or influence their behavior, including viability, long-term metabolic cell activity | NR | Transfection with protamine sulfate leads to a higher uptake |
201166 | Mesoporous silica-coated hollow manganese oxide (HMnO@mSiO2) nanoparticles | Electroporation | MnO nanoparticles were prepared, stabilized, and coated with a silica coating | MRI tracking of MSC using HMnO@mSiO2 as a positive marker | Mouse | 26% with electroporation | Minimal impact on cell viability | 14 days | Significantly higher relativity versus existing manganese oxide nanoparticles |
201167 | CoPt hollow nanoparticles | Passive uptake of the nanoparticles by the cells | CoPt nanoparticles were synthesized and coated with a mixture of PEG-SH and CCALNN peptide | MRI tracking of grafted NSCs labeled with CoPt | In vitro | NR | No impact on cell viability, morphology, or proliferation at low concentrations of CoPt nanoparticles | Detectable at low cell numbers with MRI after 2 weeks | Optimized when NSCs exposed to 8 mg mL−1 and 16 mg mL−1, and CoPt for 48 hours |
200968 | SPIONs with a carboxydextran coating | Passive uptake of the nanoparticles by the cells by endoplasmic absorbtion | MSCs culture medium was incubated for 24 h with Ferucarbotran | Labeling and therefore tracking MSCs in the kidney of a dog | Dog | PLL coating Has a higher labeling efficiency than ferumoxide |
Impaired viability and/or apoptosis at higher conc. No affect on cell viability and proliferation |
NR | Can label efficiently without transfer agent |
200969 | SPIO@SiO2-NH2 | Passive uptake of the nanoparticles by the cells | Polyhedral crystalline SPIO nanoparticles were prepared by a coprecipitation method | Tracking MSCs using SPIO@SiO2-NH2 with MRI | Rabbit | Increased MSC-labeling effects | Displayed normal nuclear morphology, apoptosis, and necrosis changes were not observed | 12 weeks | NR |
201070 | Chitosan–SPIONs coated in PLL | Passive uptake of the nanoparticle by the cells using endocytosis | Chitosan−SPIO synthesized by a sono-chemical method followed by a chitosan coating process | Label and track hBM−MSC using MRI | Rabbit | Almost 100% | Did not show any cytotoxicity up to a 200 mg Fe/mL concentration | 2 weeks | NR |
200760 | MGIO | Passive uptake of the nanoparticles by the cells via endocytosis | Nonmagnetic PMG synthesized then magnetized by the coprecipitation of iron salt to form primary iron oxide cores within PMG | Labeling hfMSCs for MRI tracking with MGIO | Rat | 97% | There was no affect on cellular proliferation | M600 particles could be detected even after four cellular divisions | M600 achieved a five- to sevenfold higher sensitivity for MRI detection than ferucarbotran |
200971 | SPION coated with starch | Passive uptake by the cells | SPIONs coated in starch were synthesized. Incubation with nanoparticles in the cell culture medium |
Labeling and tracking MSCs using SPIONs | NR | Uptake was proven but not quantified | Cells able to differentiate into stromal tissue, including bone and fat | 28 days; could visualize 1,000 MSCs | No MRI signal with the use of free iron- or dead iron-labeled MSCs |
Abbreviations: MNPs, magnetic nanoparticles; MRI, magnetic resonance imaging; SPIONs, superparamagnetic nanoparticles; PLL, poly-L-lysine; MSC, mesenchymal cells; NR, not reported; USPIO-PS, ultrasmall superparamagnetic iron oxide; hADSCs, human adipose-derived stem cells; FE-PRO, ferumoxide-protamine sulfate complex; hB, human bone; CoPt, cobalt platinum; PEG-SH, polyethylene glycol; CCALNN, cysteine-cystein-alanine-leucine-asparagine; NSC, neural stem cells; SPIO, superparamagnetic iron oxide; MGIO, microgel iron oxide; PMG, precursor microgel; hfMSC, human fetal mesenchymal cells.